Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Red and near-infrared light therapy (RLT) supports skin barrier function by increasing lipid production, stimulating collagen synthesis, and reducing inflammation, making it a helpful adjunct for managing fungal acne (Malassezia folliculitis). However, RLT does not directly kill Malassezia yeast, so it works best when combined with gentle cleansing, barrier-supportive serums, and targeted antifungal treatments.
Optimal protocols, safety precautions, and monitoring skin response all play a role in getting results without irritation. Because fungal acne mimics other breakouts—like bacterial acne, eczema, or rosacea—choosing the wrong treatment can worsen symptoms and delay healing. Before starting or adjusting your routine, take a free, instant, online symptom check to clarify what's really affecting your skin and confidently plan your next steps.
Reviewed for medical accuracy: 07/10/2026
Strengthening the Barrier: Is RLT Safe for Fungal Issues?
Red light therapy (RLT) has surged in popularity for its skin-healing benefits—everything from boosting collagen to soothing inflammation. If you're dealing with fungal acne (Malassezia folliculitis) or simply want to support a healthy skin barrier, you might wonder: can RLT help without making things worse? Below, we explore the science, safety, and practical tips for using red and near-infrared light when fungal issues are in play.
RLT uses low-level wavelengths (typically 600–700 nm for red light and 800–1,100 nm for near-infrared) to penetrate the skin:
RLT devices range from hand-held panels to full-face masks. Sessions usually last 5–20 minutes, several times per week.
Your skin barrier (stratum corneum) is the front-line defense against microbes, irritants, and moisture loss. When it's compromised, you may notice:
Key barrier components:
Supporting barrier health means nurturing these elements—RLT can play a role.
Clinical studies highlight several barrier-boosting effects of RLT:
In plain terms, RLT trains your skin cells to work more efficiently, creating a tighter, more resilient barrier.
Fungal acne (Malassezia folliculitis) isn't caused by Propionibacterium acnes but by an overgrowth of Malassezia yeast in hair follicles. Signs include:
Conventional approaches focus on antifungal agents (e.g., topical ketoconazole, oral itraconazole) and barrier care.
Direct antifungal action from red or near-infrared light (without photosensitizers) is limited:
In other words, RLT is unlikely to cure fungal acne on its own but can improve skin comfort and barrier function, making adjunctive therapy more effective.
Red light therapy is generally safe when used properly:
Still, keep these tips in mind:
If you have a weakened immune system or are on photosensitizing medications, consult your dermatologist before starting RLT.
Keep track of:
If you notice worsening of lesions, increased itching, or signs of secondary infection (pain, swelling, warmth), pause RLT and seek medical advice. Unsure whether your skin symptoms need professional attention? Use Ubie's free AI symptom checker to get personalized insights about your condition and learn what steps to take next.
While RLT is low-risk, fungal acne can sometimes mask other conditions or lead to complications. Speak to a healthcare professional if you experience:
Always discuss any treatment that could be life-threatening or serious with your doctor.
By understanding both the strengths and limits of RLT, you can harness its barrier-boosting power without compromising your fight against fungal acne. If you're experiencing confusing symptoms or want to understand whether your skin condition requires medical care, try Ubie's AI-powered symptom assessment tool for quick, personalized guidance. Your skin health—barrier and all—deserves expert guidance.
(References)
* Fekrazad R, Pourhajibagher M, Chiniforush N, Ghoreishizadeh M, Shariat A, Tarfi A, Ghaffari M, Bahador A. Photobiomodulation for Fungal Infections: A Review. J Lasers Med Sci. 2018 Fall;9(4):226-231. doi: 10.15171/jlms.2018.094. PMID: 30559600; PMCID: PMC6289069.
* Nambi P, Ramasamy V, Kumar M, Selvam A. Photobiomodulation in the Management of Onychomycosis: A Systematic Review. Cureus. 2023 Sep 16;15(9):e45366. doi: 10.7759/cureus.45366. PMID: 37731737; PMCID: PMC10507204.
* Han M, Wang T, Gao Y, Wang H, Zhang T. Low-level laser therapy in the treatment of onychomycosis: a systematic review and meta-analysis. Lasers Med Sci. 2023 Nov;38(1):257. doi: 10.1007/s10103-023-03914-y. PMID: 37626359.
* Huang YC, Chiang HH, Chan CC, Fang HW, Cheng YC, Lee JJ. Clinical Efficacy of Low-Level Laser Therapy for Tinea Pedis: A Pilot Study. Photomed Laser Surg. 2019 Sep;37(9):571-576. doi: 10.1089/pho.2019.4627. PMID: 31338872.
* Gholamrezaei M, Kaveh S, Nikounezhad N, Jabbari R, Hamidi M, Asadi F, Vahidi M, Azarian A. Anti-inflammatory and immunomodulatory effects of photobiomodulation (PBM) therapy in dermatology. Lasers Med Sci. 2023 Dec;38(1):268. doi: 10.1007/s10103-023-03978-w. PMID: 37453629.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.